PDF-This summary of 510(k) safety and effectiveness information is being s

Author : jaena | Published Date : 2020-11-23

Exhibit1 JUN 6 62012 51000 SUMMARY accordance with the requirements of SMDA 1990 and 21 CFR

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "This summary of 510(k) safety and effect..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

This summary of 510(k) safety and effectiveness information is being s: Transcript

Exhibit1 JUN 6 62012 51000 SUMMARY accordance with the requirements of SMDA 1990 and 21 CFR. G304K2D Drawing No LP0888 Released 0813 Tel 1 717 7676511 Fax 1 717 7640839 wwwredlionnet US LISTED IND CONT EQ 22SV 573935739057376 574245742357431574135742657376574265741357425574295741757426574135742157413574225742857427 574215746157459574605737 3353 Proposed Regulatory Class Class 11 Product Codes 87MEH S7LZO S7LWJ 87KWZ 87KWY S7KWL 87JD1 87LPH For Information contact Valerie Giambanco Regulatory Affairs Specialist Howmedica Osteonics Corp 325 Corporate Drive Mahwah NJ 07430 Phone 201 83162 Summary 2 Introduction 3 Scope and Application of these Guidelines 4 Responsibilities 41 Duties of Employers 42 Duties of Employees 5 Potential Effects of Exposure to Cytotoxic Drugs 51 Acute Effects 52 Chronic Effects 53 Employees who are Pregnant Division of Therapeutic Drugs for Non-Food Animals. Office of New Animal Drug Evaluation. USFDA Center for Veterinary Medicine. Effectiveness Evaluation for Therapeutic Drugs for Non-Food Animals. 2. Year End Summary. What is it?. Quick reference to the agronomic history of a field.. Prepared at the end of each cropping season.. Stored in an easily accessible location for future reference.. Year End Summary. Background. IN.PACT SFA Trial: Overview. IN.PACT SFA Trial: Primary Outcomes. IN.PACT SFA Trial: . 4-Year Follow-up Assessment . IN.PACT SFA Trial: . Baseline Characteristics. IN.PACT SFA Trial: . Primary Patency Through . Asset Safeguarding and Data Integrity. Effectiveness and Efficiency . Drs. . Haryono. , . Ak. . . M.Com. . & Dimas M. Widiantoro, SE., . S.Kom. ., M.Sc.. Pics. from : http. ://www.pragroup.ca/Services/InformationTechnology/tabid/70/Default.aspx. of Stimwave Freedom SCS System (Primary Predicate) K170141 K162161 The 510(k) history of the Stimwave device includes design changes over time. The original Medtronic and ANS devices are part of the CAS Number: 96-29-7 CAS Name: 2-Butanone oxime EC (EINECS) Number: 202-496-6 Methyl ethyl ketoxime (MEKO) is an essential chemical used as an anti-skinning agent in paints and lacquers, as a bloc 5.4 Drive chain5.5 Fuel supply5.8 Threaded joints6. Information on adjustment and maintenance operations on the kart 6.1 Brake discs replacement6.2 Mechanical brake system6.3 Hydraulic brake system6.4 /ko S/vZ7LThe ProtectiScope CS Non-intrapull colonoscope is designed for use in both diagnostic andtherapeutic colonoscopy procedures The insertion tube is designed to accommodate biopsytools and equi Intended Use / Indications for Use e dl tThe Medic4AII Telemedicine System Model VMS-01 is intended to collectand transmit physiological information such as non-invasive blood pressure viastandard tel PMA P080002: FDA Summary of Safety and Effectiveness Data page 3 9 This PMA and the IX, the At the the two PMA P080002: FDA Summary of Safety and Effectiveness Data page 11 t? May 25; among couples Device DescriptionThe Access Intact PTH reagents, calibrators, and the Access Immunoassay Analyzers (Access,Access 2, Synchron LXi 725, UniCel DxC600i, and UniCel Dxl 800) comprise the AccessImmunoass

Download Document

Here is the link to download the presentation.
"This summary of 510(k) safety and effectiveness information is being s"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.